|
|
||||||||




*
Pulmonary/Critical Care Medicine Branch, National Heart, Lung, and Blood Institute, and
Laboratory of Cellular and Molecular Biology, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892; and
Section for Molecular Signaling, Department of Cell and Molecular Biology, Lund University, Lund, Sweden
In FDCP2 myeloid cells, IL-4 activated cyclic nucleotide
phosphodiesterases PDE3 and PDE4, whereas IL-3, granulocyte-macrophage
CSF (GM-CSF), and phorbol ester (PMA) selectively activated PDE4. IL-4
(not IL-3 or GM-CSF) induced tyrosine phosphorylation of
insulin-receptor substrate-2 (IRS-2) and its association with
phosphatidylinositol 3-kinase (PI3-K). TNF-
, AG-490 (Janus kinase
inhibitor), and wortmannin (PI3-K inhibitor) inhibited activation of
PDE3 and PDE4 by IL-4. TNF-
also blocked IL-4-induced tyrosine
phosphorylation of IRS-2, but not of STAT6. AG-490 and wortmannin, not
TNF-
, inhibited activation of PDE4 by IL-3. These results suggested
that IL-4-induced activation of PDE3 and PDE4 was downstream of
IRS-2/PI3-K, not STAT6, and that inhibition of tyrosine phosphorylation
of IRS molecules might be one mechnism whereby TNF-
could
selectively regulate activities of cytokines that utilized IRS proteins
as signal transducers. RO31-7549 (protein kinase C (PKC) inhibitor)
inhibited activation of PDE4 by PMA. IL-4, IL-3, and GM-CSF activated
mitogen-activated protein (MAP) kinase and protein kinase B via PI3-K
signals; PMA activated only MAP kinase via PKC signals. The MAP kinase
kinase (MEK-1) inhibitor PD98059 inhibited IL-4-, IL-3-, and
PMA-induced activation of MAP kinase and PDE4, but not IL-4-induced
activation of PDE3. In FDCP2 cells transfected with constitutively
activated MEK, MAP kinase and PDE4, not PDE3, were activated. Thus, in
FDCP2 cells, PDE4 can be activated by overlapping MAP kinase-dependent
pathways involving PI3-K (IL-4, IL-3, GM-CSF) or PKC (PMA), but
selective activation of PDE3 by IL-4 is MAP kinase independent (but
perhaps IRS-2/PI3-K dependent).
This article has been cited by other articles:
![]() |
H. Wang and N. K. Edens mRNA expression and antilipolytic role of phosphodiesterase 4 in rat adipocytes in vitro J. Lipid Res., May 1, 2007; 48(5): 1099 - 1107. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Lin and J. A. Boyce IL-4 Regulates MEK Expression Required for Lysophosphatidic Acid-Mediated Chemokine Generation by Human Mast Cells J. Immunol., October 15, 2005; 175(8): 5430 - 5438. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-F. Tang, Y.-H. Song, J.-C. Chen, J.-Q. Chen, and P. Wang Upregulation of Phosphodiesterase-4 in the Lung of Allergic Rats Am. J. Respir. Crit. Care Med., April 15, 2005; 171(8): 823 - 828. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Fujitsu, K. Fukuda, K. Kimura, K. Seki, N. Kumagai, and T. Nishida Protection of Human Conjunctival Fibroblasts from NO-Induced Apoptosis by Interleukin-4 or Interleukin-13 Invest. Ophthalmol. Vis. Sci., March 1, 2005; 46(3): 797 - 802. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Mei, L. S. Holst, T. R. Landstrom, C. Holm, D. Brindley, V. Manganiello, and E. Degerman C2-Ceramide Influences the Expression and Insulin-Mediated Regulation of Cyclic Nucleotide Phosphodiesterase 3B and Lipolysis in 3T3-L1 Adipocytes Diabetes, March 1, 2002; 51(3): 631 - 637. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Moon, R. Lee, R. Near, L. Weintraub, S. Wolda, and A. Lerner Inhibition of PDE3B Augments PDE4 Inhibitor-induced Apoptosis in a Subset of Patients with Chronic Lymphocytic Leukemia Clin. Cancer Res., February 1, 2002; 8(2): 589 - 595. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Baillie, S. J. MacKenzie, and M. D. Houslay Phorbol 12-myristate 13-acetate Triggers the Protein Kinase A-Mediated Phosphorylation and Activation of the PDE4D5 cAMP Phosphodiesterase in Human Aortic Smooth Muscle Cells through a Route Involving Extracellular Signal Regulated Kinase (ERK) Mol. Pharmacol., November 1, 2001; 60(5): 1100 - 1111. [Abstract] [Full Text] |
||||
![]() |
L. ORourke, S. J. Yeaman, and P. R. Shepherd Insulin and Leptin Acutely Regulate Cholesterol Ester Metabolism in Macrophages by Novel Signaling Pathways Diabetes, May 1, 2001; 50(5): 955 - 961. [Abstract] [Full Text] |
||||
![]() |
D. M. McKay, F. Botelho, P. J. M. Ceponis, and C. D. Richards Superantigen immune stimulation activates epithelial STAT-1 and PI 3-K: PI 3-K regulation of permeability Am J Physiol Gastrointest Liver Physiol, November 1, 2000; 279(5): G1094 - G1103. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J. MacKenzie, G. S. Baillie, I. McPhee, G. B. Bolger, and M. D. Houslay ERK2 Mitogen-activated Protein Kinase Binding, Phosphorylation, and Regulation of the PDE4D cAMP-specific Phosphodiesterases. THE INVOLVEMENT OF COOH-TERMINAL DOCKING SITES AND NH2-TERMINAL UCR REGIONS J. Biol. Chem., May 26, 2000; 275(22): 16609 - 16617. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Ahmad, L.-N. Cong, L. Stenson Holst, L.-M. Wang, T. Rahn Landstrom, J. H. Pierce, M. J. Quon, E. Degerman, and V. C. Manganiello Cyclic Nucleotide Phosphodiesterase 3B Is a Downstream Target of Protein Kinase B and May Be Involved in Regulation of Effects of Protein Kinase B on Thymidine Incorporation in FDCP2 Cells J. Immunol., May 1, 2000; 164(9): 4678 - 4688. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J. M. Ceponis, F. Botelho, C. D. Richards, and D. M. McKay Interleukins 4 and 13 Increase Intestinal Epithelial Permeability by a Phosphatidylinositol 3-Kinase Pathway. LACK OF EVIDENCE FOR STAT 6 INVOLVEMENT J. Biol. Chem., September 8, 2000; 275(37): 29132 - 29137. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Croniger, C. Millward, J. Yang, Y. Kawai, I. J. Arinze, S. Liu, M. Harada-Shiba, K. Chakravarty, J. E. Friedman, V. Poli, et al. Mice with a Deletion in the Gene for CCAAT/Enhancer-binding Protein beta Have an Attenuated Response to cAMP and Impaired Carbohydrate Metabolism J. Biol. Chem., January 5, 2001; 276(1): 629 - 638. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. E. Moore, T. L. Church, D. D. Chism, R. A. Panettieri Jr., and S. A. Shore IL-13 and IL-4 cause eotaxin release in human airway smooth muscle cells: a role for ERK Am J Physiol Lung Cell Mol Physiol, April 1, 2002; 282(4): L847 - L853. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |